Home Health Study points to increased risk of harm from cannabis across Europe –...

Study points to increased risk of harm from cannabis across Europe – Medical Xpress

46
0
SHARE
Study points to increased risk of harm from cannabis across Europe – Medical Xpress
January 1, 2019, University of Bath

Credit: CC0 Public Domain

Cannabis resin and herbal cannabis have significantly increased in potency and in price, according to the first study to investigate changes in cannabis across Europe.

The study, published today in the journal Addiction by researchers from the University of Bath and King’s College London, draws on data collected from across 28 EU Member states, as well as Norway and Turkey by the European Monitoring Centre for Drugs and Drug Addiction.

The findings show that for , concentrations of delta-9-tetrahydrocannabinol (‘THC’ – the main psychoactive constituent of cannabis) increased by a similar amount each year, from 5% in 2006 to 10% in 2016.

For cannabis resin (or hash), THC concentrations were relatively stable from 2006 to 2011 (from 8% to 10%) but then increased rapidly from 2011 to 2016 (from 10% to 17%). The price of cannabis resin also increased, but to a lesser extent than for herbal cannabis.

Lead author Dr. Tom Freeman from the Addiction and Mental Health Group within the Department of Psychology at the University of Bath, said: “These findings show that cannabis resin has changed rapidly across Europe, resulting in a more potent and better value product.”

Unlike herbal cannabis, cannabis resin typically contains cannabidiol (CBD) in addition to THC. CBD has recently attracted considerable interest due to its potential to treat several including childhood epilepsy syndromes, psychosis and anxiety. When present in cannabis, CBD may offset some of the harmful effects of THC such as paranoia and memory impairment.

Cannabis containing higher levels of THC and / or lower levels of CBD has been linked to greater long-term harms such as the development of cannabis dependence, and an increased risk of psychotic illness. New production techniques in Morocco and Europe have increased levels of THC, but not CBD.

Dr. Freeman added: “CBD has the potential to make cannabis safer, without limiting the positive effects users seek. What we are seeing in Europe is an increase in THC and either stable or decreasing levels of CBD, potentially making cannabis more harmful. These changes in the illicit market are largely hidden from and are difficult to target by policy-makers. An alternative option could be to attempt to control THC and CBD content through regulation.”

It is estimated that 24 million people (or 7.2%) of European adults used cannabis in the last year. Across the globe 192 million people use the drug in a variety of markets, ranging from heavily sanctioned prohibition to commercialised legal sale. Cannabis policies are rapidly changing across the globe.

Recreational use is now legalised in Canada and several US states, and medical use is permitted in many more countries, including very recently in the UK.


Explore further:
Nearly all cannabis seized by UK police is high-strength ‘skunk’– here’s why we should be worried

More information:
Tom P. Freeman et al, Increasing potency and price of cannabis in Europe, 2006-2016, Addiction (2018). DOI: 10.1111/add.14525


Related Stories



Scientists identify 35 genes associated with cannabis use


August 28, 2018

A large-scale genetic study found that some of the same genes associated with the use of cannabis are also associated with certain personality types and psychiatric conditions. The study, published in Nature Neuroscience, …

Daily cannabis use is on the rise in American adults


June 20, 2018

Cannabis use may be decreasing among teens, but a new study by researchers at Columbia University’s Mailman School of Public Health showed that American adults have increasingly used cannabis daily since 2007. The findings …

Recommended for you



Drugs of abuse: Identifying the addiction circuit


December 20, 2018

What happens in the brain of a compulsive drug user? What is the difference in brain function between an addict and a person who takes a drug in a controlled manner? In an attempt solve this puzzle, neurobiologists at the …



Early postpartum opioids linked with persistent usage


December 14, 2018

Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum …



College students choose smartphones over food


November 16, 2018

University at Buffalo researchers have found that college students prefer food deprivation over smartphone deprivation, according to results from a paper in Addictive Behaviors.

4 comments


Adjust slider to filter visible comments by rank

Display comments: newest first

Read More

Leave a Reply